P+F Products + Features GmbH
Paul Shelton is currently the US Director of Clinical Development at P+F Products + Features GmbH. Previously, Paul held roles such as Senior Principal Market Development Manager at Keystone Heart and Minimally Invasive Manager, EP at AtriCure, Inc./SentreHEART. With extensive experience in the medical sales industry, Paul has consistently achieved sales goals and developed successful market strategies. Their background includes positions at companies such as SentreHEART, ev3, Cordis, Boston Scientific, and Astra Zeneca. Paul's education includes a BBA in Marketing/Psychology from Francis Marion University and a preceptorship in Cardiology/Immunology from Tufts University School of Medicine.
This person is not in any offices
P+F Products + Features GmbH
P+F Products + Features GmbH is a medical technology company focused on research, development, and manufacture of innovative minimally invasive solutions in the field of cardiology. Our R&D capabilities are the foundation of our approach to innovation while developing new products and enhancing existing ones; our purpose is to leverage these capabilities to generate distinctive value and expand access to state-of-the-art technology for patients and healthcare providers worldwide. Having more than 25 years of experience in the medical field, the leadership team of P+F has built up a complete infrastructure for research, development, manufacture, and distribution in order to deliver significant innovations and add economic value to its customers. P+F is headquartered in Vienna, Austria, and has operation facilities in Germany, Portugal, Spain, and Brazil.